{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:06:31Z","timestamp":1788937591686,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04258-6","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:16:18Z","timestamp":1788934578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Optimization of Puerarin-loaded Proniosomal gel for topical ocular delivery: an in vitro and ex vivo evaluation"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7402-3366","authenticated-orcid":false,"given":"Shubham N.","family":"Kanawade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3164-5472","authenticated-orcid":false,"given":"Harish R.","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-1811","authenticated-orcid":false,"given":"Salim G.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip S.","family":"Pawde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-1582","authenticated-orcid":false,"given":"Ravindra B.","family":"Laware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7862-6654","authenticated-orcid":false,"given":"Dhruv R.","family":"Vikhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5903-6185","authenticated-orcid":false,"given":"Rahul R.","family":"Kunkulol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"4258_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/08820538.2025.2536228","volume":"41","author":"V Anitha","year":"2026","unstructured":"Anitha V, Rhagavan A, Rao SK, Srinivasan B, Kusumesh R, Nallasamy N et al (2026) Ocular surface disorders in children: a comprehensive review of pathogenesis, diagnosis, and management. Semin Ophthalmol 41:260\u2013276. https:\/\/doi.org\/10.1080\/08820538.2025.2536228","journal-title":"Semin Ophthalmol"},{"key":"4258_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jtos.2023.08.009","volume":"30","author":"JP Craig","year":"2023","unstructured":"Craig JP, Alves M, Wolffsohn JS, Downie LE, Efron N, Galor A et al (2023) TFOS lifestyle report executive summary: a lifestyle epidemic - ocular surface disease. Ocul Surf 30:240\u2013253. https:\/\/doi.org\/10.1016\/j.jtos.2023.08.009","journal-title":"Ocul Surf"},{"key":"4258_CR3","doi-asserted-by":"publisher","unstructured":"Doctor MB, Basu S (2022) Lacrimal gland insufficiency in aqueous deficiency dry eye disease: recent advances in pathogenesis, diagnosis, and treatment. Semin Ophthalmol 37:801\u2013812. https:\/\/doi.org\/10.1080\/08820538.2022.2075706","DOI":"10.1080\/08820538.2022.2075706"},{"key":"4258_CR4","doi-asserted-by":"publisher","unstructured":"Shuaibu AO, Bazuaye KN, Okpunor E (2026) A hospital based study on the attributable risk factors of dry eye. https:\/\/doi.org\/10.21203\/rs.3.rs-7841959\/v1","DOI":"10.21203\/rs.3.rs-7841959\/v1"},{"key":"4258_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010103","volume":"14","author":"SC Huang","year":"2025","unstructured":"Huang SC, Lei YP, Hsiao MC, Hsieh YK, Tang QP, Chen C et al (2025) Multicomponent dietary supplementation: impact on tear secretion and ocular surface inflammation in dry eye syndrome patients. Antioxidants (Basel) 14:103. https:\/\/doi.org\/10.3390\/antiox14010103","journal-title":"Antioxidants (Basel)"},{"key":"4258_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112121","volume":"11","author":"D Wang","year":"2022","unstructured":"Wang D, Bu T, Li Y, He Y, Yang F, Zou L (2022) Pharmacological activity, pharmacokinetics, and clinical research progress of puerarin. Antioxidants (Basel) 11:2121. https:\/\/doi.org\/10.3390\/antiox11112121","journal-title":"Antioxidants (Basel)"},{"key":"4258_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114581","volume":"162","author":"X Liu","year":"2023","unstructured":"Liu X, Huang R, Wan J (2023) Puerarin: a potential natural neuroprotective agent for neurological disorders. Biomed Pharmacother 162:114581. https:\/\/doi.org\/10.1016\/j.biopha.2023.114581","journal-title":"Biomed Pharmacother"},{"key":"4258_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156048","volume":"135","author":"Q Tao","year":"2024","unstructured":"Tao Q, Liang Q, Fu Y, Qian J, Xu J, Zhu Y et al (2024) Puerarin ameliorates colitis by direct suppression of macrophage M1 polarization in DSS mice. Phytomedicine 135:156048. https:\/\/doi.org\/10.1016\/j.phymed.2024.156048","journal-title":"Phytomedicine"},{"key":"4258_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.780419","volume":"12","author":"Y Bai","year":"2022","unstructured":"Bai Y, Han L, Qian J, Wang H (2022) Molecular mechanism of puerarin against diabetes and its complications. Front Pharmacol 12:780419. https:\/\/doi.org\/10.3389\/fphar.2021.780419","journal-title":"Front Pharmacol"},{"key":"4258_CR10","first-page":"25","volume":"2","author":"S Vaishnav","year":"2024","unstructured":"Vaishnav S, Khirwadkar DP, Mandoria DN, Dashora DK, Dubey DD, Bhargava DT (2024) Gel with proniosome: a pioneering approach for drug release. Clin Images Case Rep 2:25\u201333","journal-title":"Clin Images Case Rep"},{"key":"4258_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-031-30529-0_4","volume-title":"Nanomaterials-based drug delivery systems for therapeutic and theranostic applications","author":"S Mahajan","year":"2023","unstructured":"Mahajan S, Maji I, Mehra NK, Singh PK (2023) Vesicular nanomaterials: types and therapeutic uses. In: Pardeshi CV (ed) Nanomaterials-based drug delivery systems for therapeutic and theranostic applications. Springer International Publishing, Cham, pp 99\u2013145. https:\/\/doi.org\/10.1007\/978-3-031-30529-0_4"},{"key":"4258_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070816","volume":"15","author":"SW El-Far","year":"2022","unstructured":"El-Far SW, Abo El-Enin HA, Abdou EM, Nafea OE, Abdelmonem R (2022) Targeting colorectal cancer cells with niosomes systems loaded with two anticancer drugs models; comparative in vitro and anticancer studies. Pharmaceuticals 15:816. https:\/\/doi.org\/10.3390\/ph15070816","journal-title":"Pharmaceuticals"},{"key":"4258_CR13","doi-asserted-by":"publisher","DOI":"10.37349\/ebmx.2025.101355","volume":"2","author":"S Alhabardi","year":"2025","unstructured":"Alhabardi S, Almurshedi A, Alnassar S, Alshabanah S, Alsabih N, Alotaibi A et al (2025) Osimertinib nano-niosomes: surfactant effects, release kinetics, and cytotoxicity studies. Explor BioMat-X 2:101355. https:\/\/doi.org\/10.37349\/ebmx.2025.101355","journal-title":"Explor BioMat-X"},{"key":"4258_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.61427\/jcpr.v3.i2.2023.88","volume":"3","author":"UK Thummala","year":"2023","unstructured":"Thummala UK, Vallabhareddy PS, Sarella PNK (2023) Enhancing oral absorption of orlistat through gastroretentive mucoadhesive pellets: formulation and evaluation. J Clin Pharm Res 3:9\u201317. https:\/\/doi.org\/10.61427\/jcpr.v3.i2.2023.88","journal-title":"J Clin Pharm Res"},{"key":"4258_CR15","doi-asserted-by":"publisher","DOI":"10.62877\/90-IJCBS-24-25-19-90","author":"H Bella Afirosa","year":"2024","unstructured":"Bella Afirosa H, Suzery M, Cahyono B (2024) Quantitative analysis of andrographolide in sambiloto herbal preparation using UV-Vis, HPLC, and 1H-NMR with dibenzyl ether as internal standard. Int J Chem Biochem Sci. https:\/\/doi.org\/10.62877\/90-IJCBS-24-25-19-90","journal-title":"Int J Chem Biochem Sci"},{"key":"4258_CR16","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02667-9","volume":"24","author":"E Rahimpour","year":"2023","unstructured":"Rahimpour E, Moradi M, Sheikhi-Sovari A, Rezaei H, Rezaei H, Jouyban-Gharamaleki V et al (2023) Comparative drug solubility studies using shake-flask versus a laser-based robotic method. AAPS PharmSciTech 24:207. https:\/\/doi.org\/10.1208\/s12249-023-02667-9","journal-title":"AAPS PharmSciTech"},{"key":"4258_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ente.202400365","volume":"12","author":"C Bracht","year":"2024","unstructured":"Bracht C, Preitschopf T, Sch\u00f6neich M, Neff T, Kallfa\u00df C, Finze M (2024) Influence of crucible types on thermal stability analysis of Li-ion battery components by thermogravimetric analysis\u2013differential scanning calorimetry. Energy Technol 12:2400365. https:\/\/doi.org\/10.1002\/ente.202400365","journal-title":"Energy Technol"},{"key":"4258_CR18","volume-title":"Polylactic acid-based nanocellulose and cellulose composites","author":"NM Nurazzi","year":"2022","unstructured":"Nurazzi NM, Abdullah N, Norrrahim MNF, Kamarudin SH, Ahmad S, Shazleen SS et al (2022) Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) of PLA\/cellulose composites. Polylactic acid-based nanocellulose and cellulose composites. CRC Press, Boca Raton"},{"key":"4258_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/molecules30030684","volume":"30","author":"S Pasieczna-Patkowska","year":"2025","unstructured":"Pasieczna-Patkowska S, Cichy M, Flieger J (2025) Application of Fourier transform infrared (FTIR) spectroscopy in characterization of green synthesized nanoparticles. Molecules 30:684. https:\/\/doi.org\/10.3390\/molecules30030684","journal-title":"Molecules"},{"key":"4258_CR20","doi-asserted-by":"publisher","first-page":"09002","DOI":"10.1051\/epjconf\/202532309002","volume":"323","author":"M Sega","year":"2025","unstructured":"Sega M, Durbiano F, Pavarelli S, Pennecchi FR, Rolle F (2025) Comparison of cavity ring-down spectroscopy and Fourier transform infrared spectroscopy for the isotopic composition determination of CRMs of CO2 in air. EPJ Web Conf 323:09002. https:\/\/doi.org\/10.1051\/epjconf\/202532309002","journal-title":"EPJ Web Conf"},{"key":"4258_CR21","doi-asserted-by":"publisher","first-page":"16346","DOI":"10.1021\/acsomega.3c10506","volume":"9","author":"MA Mujtaba","year":"2024","unstructured":"Mujtaba MA, Kaleem M, Chaware R, Ingole A, Asiri YI, Hassan MZ et al (2024) Development and optimization of proniosomal formulation of irbesartan using a Box-Behnken design to enhance oral bioavailability: physicochemical characterization and in vivo assessment. ACS Omega 9:16346\u201316357. https:\/\/doi.org\/10.1021\/acsomega.3c10506","journal-title":"ACS Omega"},{"key":"4258_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28891-8","volume":"13","author":"J Darson","year":"2023","unstructured":"Darson J, Thirunellai Seshadri R, Katariya K, Mohan M, Srinivas Kamath M, Etyala MA et al (2023) Design development and optimisation of multifunctional doxorubicin-loaded indocyanine green proniosomal gel derived niosomes for tumour management. Sci Rep 13:1697. https:\/\/doi.org\/10.1038\/s41598-023-28891-8","journal-title":"Sci Rep"},{"key":"4258_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105728","volume":"96","author":"NF Younes","year":"2024","unstructured":"Younes NF, Sayed S, Hassan M, Ahmed S (2024) Engineered lecithin-based proniosomes for enhanced trans-tympanic permeation: in vitro, microbiological, ex vivo and in vivo evaluation. J Drug Deliv Sci Technol 96:105728. https:\/\/doi.org\/10.1016\/j.jddst.2024.105728","journal-title":"J Drug Deliv Sci Technol"},{"key":"4258_CR24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s13346-022-01217-3","volume":"13","author":"AM Mohsen","year":"2023","unstructured":"Mohsen AM, El-Hashemy HA, Salama A, Darwish AB (2023) Formulation of tizanidine hydrochloride-loaded provesicular system for improved oral delivery and therapeutic activity employing a 23 full factorial design. Drug Deliv Transl Res 13:580\u2013592. https:\/\/doi.org\/10.1007\/s13346-022-01217-3","journal-title":"Drug Deliv Transl Res"},{"key":"4258_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.22159\/ijpps.2022v14i1.43237","volume":"14","author":"RP Baig","year":"2022","unstructured":"Baig RP, Wais M (2022) Formulation and development of proniosomal gel for topical delivery of amphotericin B. Int J Pharm Pharm Sci 14:37\u201349. https:\/\/doi.org\/10.22159\/ijpps.2022v14i1.43237","journal-title":"Int J Pharm Pharm Sci"},{"key":"4258_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104639","volume":"86","author":"P Sakdiset","year":"2023","unstructured":"Sakdiset P, Arce FJ, See GL, Sawatdee S, Sae Yoon A (2023) Preparation and characterization of lidocaine HCl-loaded proniosome gels with skin penetration enhancers. J Drug Deliv Sci Technol 86:104639. https:\/\/doi.org\/10.1016\/j.jddst.2023.104639","journal-title":"J Drug Deliv Sci Technol"},{"key":"4258_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104665","volume":"86","author":"HH Attia","year":"2023","unstructured":"Attia HH, Shaker DS, ElMeshad A, El-Kayal M (2023) Optimization and in vitro assessment of the effectiveness of carvedilol-loaded proniosomal gels as a promising therapeutic approach for the topical treatment of skin cancer. J Drug Deliv Sci Technol 86:104665. https:\/\/doi.org\/10.1016\/j.jddst.2023.104665","journal-title":"J Drug Deliv Sci Technol"},{"key":"4258_CR28","doi-asserted-by":"publisher","unstructured":"Kumar S, Soni A, Dahiya DP, Kumari C (2023) Preparation and formulation of topical proniosomal gel of an anti-inflammatory drug ferulic acid. World J Pharm Res 12(16):222\u2013235. https:\/\/doi.org\/10.20959\/wjpr202316-29606","DOI":"10.20959\/wjpr202316-29606"},{"key":"4258_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/gels9080597","volume":"9","author":"SA Mohamed","year":"2023","unstructured":"Mohamed SA, Rofaeil RR, Salem H, Elrehany M, Asiri YI, Al Fatease A et al (2023) Proniosomal gel-loaded phosphodiesterase inhibitors (sildenafil, vardenafil, and tadalafil): prospects for topical penile therapy for treatment of erectile dysfunction. Gels 9:597. https:\/\/doi.org\/10.3390\/gels9080597","journal-title":"Gels"},{"key":"4258_CR30","doi-asserted-by":"publisher","first-page":"666","DOI":"10.5530\/ijpi.13.3.083","volume":"13","author":"S Vashist","year":"2023","unstructured":"Vashist S, Gadewar MM (2023) Preparation and characterization of mucoadhesive proniosomal gel of curcumin with thiolated chitosan for the treatment of oral mucositis. Int J Pharm Investig 13:666\u2013672. https:\/\/doi.org\/10.5530\/ijpi.13.3.083","journal-title":"Int J Pharm Investig"},{"key":"4258_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12247-026-10374-8","volume":"21","author":"R Godge","year":"2026","unstructured":"Godge R, Gumnar R, Vikhe K, Ghogare R, Mankar S (2026) Development and optimization of a tapinarof loaded proniosomal gel to treat plaque psoriasis. J Pharm Innov 21:144. https:\/\/doi.org\/10.1007\/s12247-026-10374-8","journal-title":"J Pharm Innov"},{"key":"4258_CR32","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acs.molpharmaceut.3c00195","volume":"20","author":"I De Hoon","year":"2023","unstructured":"De Hoon I, Boukherroub R, De Smedt SC, Szunerits S, Sauvage F (2023) In vitro and ex vivo models for assessing drug permeation across the cornea. Mol Pharm 20:3298\u20133319. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00195","journal-title":"Mol Pharm"},{"key":"4258_CR33","doi-asserted-by":"publisher","unstructured":"Ahmed S, Amin MM, El-Korany SM, Sayed S (2022) Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: preparation, in vitro characterization, ex vivo and in vivo assessments. Drug Deliv 29:2428\u20132441. https:\/\/doi.org\/10.1080\/10717544.2022.2103600","DOI":"10.1080\/10717544.2022.2103600"},{"key":"4258_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2023.100201","volume":"6","author":"OA Agha","year":"2023","unstructured":"Agha OA, Girgis GNS, El-Sokkary MMA, Soliman OAE (2023) Spanlastic-laden in situ gel as a promising approach for ocular delivery of levofloxacin: in vitro characterization, microbiological assessment, corneal permeability and in vivo study. Int J Pharm X 6:100201. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100201","journal-title":"Int J Pharm X"},{"key":"4258_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103517","volume":"74","author":"SN Sanap","year":"2022","unstructured":"Sanap SN, Bisen AC, Mishra A, Biswas A, Agrawal S, Yadav KS et al (2022) QbD based antifungal drug-loaded ophthalmic liposomal formulation for the management of fungal keratitis: in vitro, ex vivo and in vivo pharmacokinetic studies. J Drug Deliv Sci Technol 74:103517. https:\/\/doi.org\/10.1016\/j.jddst.2022.103517","journal-title":"J Drug Deliv Sci Technol"},{"key":"4258_CR36","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/pharmaceutics14112324","volume":"14","author":"O Gonz\u00e1lez-Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez O, Ramirez IO, Ramirez BI, O\u2019Connell P, Ballesteros MP, Torrado JJ et al (2022) Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics 14:2324. https:\/\/doi.org\/10.3390\/pharmaceutics14112324","journal-title":"Pharmaceutics"},{"key":"4258_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.52711\/2231-5675.2023.00022","volume":"13","author":"AJ Vyas","year":"2023","unstructured":"Vyas AJ, Jadav CD, Patel AI, Patel AB, Shah SR, Sheth D et al (2023) Review on stability indicating assay method or forced degradation study: strategy and regulatory consideration. Asian J Pharm Anal 13:131\u2013139","journal-title":"Asian J Pharm Anal"},{"key":"4258_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s41120-023-00078-5","volume":"9","author":"C Latoz","year":"2023","unstructured":"Latoz C, Larkin L, Huynh-Ba K (2023) Stability considerations for drug-device combination products-21 CFR part 4 update. AAPS Open 9:10. https:\/\/doi.org\/10.1186\/s41120-023-00078-5","journal-title":"AAPS Open"},{"key":"4258_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13065-023-01028-8","volume":"17","author":"NS Al-Kadhi","year":"2023","unstructured":"Al-Kadhi NS, Mohamed MA, Ahmed HA, Nassar HF (2023) Facile synthesis and eco-friendly analytical methods for concurrent estimation of selected pharmaceutical drugs: application to quality by design, lean six sigma, and stability studies. BMC Chem 17:136. https:\/\/doi.org\/10.1186\/s13065-023-01028-8","journal-title":"BMC Chem"},{"key":"4258_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101734","volume":"31","author":"MF Aldawsari","year":"2023","unstructured":"Aldawsari MF, Khafagy ES, Moglad EH, Selim Abu Lila A (2023) Formulation optimization, in vitro and in vivo evaluation of niosomal nanocarriers for enhanced topical delivery of cetirizine. Saudi Pharm J 31:101734. https:\/\/doi.org\/10.1016\/j.jsps.2023.101734","journal-title":"Saudi Pharm J"},{"key":"4258_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1208\/pt0804086","volume":"8","author":"AB Solanki","year":"2007","unstructured":"Solanki AB, Parikh JR, Parikh RH (2007) Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design. AAPS PharmSciTech 8:43. https:\/\/doi.org\/10.1208\/pt0804086","journal-title":"AAPS PharmSciTech"},{"key":"4258_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40199-019-00242-x","volume":"27","author":"H Shah","year":"2019","unstructured":"Shah H, Nair AB, Shah J, Bharadia P, Al-Dhubiab BE (2019) Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats. DARU J Pharm Sci 27:59\u201370. https:\/\/doi.org\/10.1007\/s40199-019-00242-x","journal-title":"DARU J Pharm Sci"},{"key":"4258_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10717544.2016.1247928","volume":"24","author":"GA Abdelbary","year":"2017","unstructured":"Abdelbary GA, Amin MM, Zakaria MY (2017) Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv 24:309\u2013319. https:\/\/doi.org\/10.1080\/10717544.2016.1247928","journal-title":"Drug Deliv"},{"key":"4258_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/10717544.2019.1609622","volume":"26","author":"A Emad Eldeeb","year":"2019","unstructured":"Emad Eldeeb A, Salah S, Ghorab M (2019) Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in vitro characterization, and in vivo pharmacodynamic study. Drug Deliv 26:509\u2013521. https:\/\/doi.org\/10.1080\/10717544.2019.1609622","journal-title":"Drug Deliv"},{"key":"4258_CR45","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/nano10061191","volume":"10","author":"S Durak","year":"2020","unstructured":"Durak S, Esmaeili Rad M, Alp Yetisgin A, Eda Sutova H, Kutlu O, Cetinel S et al (2020) Niosomal drug delivery systems for ocular disease\u2014recent advances and future prospects. Nanomaterials (Basel) 10:1191. https:\/\/doi.org\/10.3390\/nano10061191","journal-title":"Nanomaterials (Basel)"},{"key":"4258_CR46","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-020-1626-2","volume":"21","author":"S Sayed","year":"2020","unstructured":"Sayed S, Abdelmoteleb M, Amin MM, Khowessah OM (2020) Effect of formulation variables and gamma sterilization on transcorneal permeation and stability of proniosomal gels as ocular platforms for antiglaucomal drug. AAPS PharmSciTech 21:87. https:\/\/doi.org\/10.1208\/s12249-020-1626-2","journal-title":"AAPS PharmSciTech"},{"key":"4258_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119835","volume":"589","author":"FA Aboali","year":"2020","unstructured":"Aboali FA, Habib DA, Elbedaiwy HM, Farid RM (2020) Curcumin-loaded proniosomal gel as a biofriendly alternative for treatment of ocular inflammation: in vitro and in vivo assessment. Int J Pharm 589:119835. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119835","journal-title":"Int J Pharm"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04258-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04258-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:16:20Z","timestamp":1788934580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04258-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4258"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04258-6","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial or non-financial interests that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that no artificial intelligence tools were used in any aspect of this manuscript preparation, including text drafting, data analysis, figure generation, or content editing. All work was conducted entirely by the authors.","order":2,"name":"Ethics","label":"Artificial intelligence disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"385"}}